Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 2.07x is 170% above its 5-year average of -2.95x, near the high end of its 5-year range (-35.59x–12.43x).
67.64% below its 12-month average of 6.40x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 11.65x.
INTEREST COVERAGE RATIO
2.07x
INTEREST COVERAGE RATIO AVG TTM
6.40x
INTEREST COVERAGE RATIO AVG 3Y
-1.23x
INTEREST COVERAGE RATIO AVG 5Y
-2.95x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-67.64%
CURRENT VS 3Y AVG
+268.00%
CURRENT VS 5Y AVG
+170.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.24x
median of 359 covered companies
CURRENT VS SECTOR MEDIAN
+148.82%
vs the sector median at left
LifeStance Health Group, Inc.
Market Cap
$4.71B
Interest Coverage Ratio
2.07x
TTM Avg
6.40x
3Y Avg
-1.23x
5Y Avg
-2.95x
Market Cap
$4.73B
Interest Coverage Ratio
-30.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.66B
Interest Coverage Ratio
-4.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.80B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.90B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.52B
Interest Coverage Ratio
-4.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.47B
Interest Coverage Ratio
5.89x
TTM Avg
3.33x
3Y Avg
3.33x
5Y Avg
4.95x
Market Cap
$4.99B
Interest Coverage Ratio
168.66x
TTM Avg
168.66x
3Y Avg
168.66x
5Y Avg
168.66x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeStance Health Group, Inc. (LFST) | $4.71B | 2.07x | 6.40x | -1.23x | -2.95x |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | -30.34x | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.66B | -4.85x | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.80B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.90B | -1.54x | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.52B | -4.22x | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.47B | 5.89x | 3.33x | 3.33x | 4.95x |
| BillionToOne, Inc. (BLLN)vs › | $4.99B | 168.66x | 168.66x | 168.66x | 168.66x |
| Erasca, Inc. (ERAS)vs › | $4.99B | N/A | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.33B | N/A | N/A | N/A | N/A |
Interest Coverage
2.1x
Debt/Equity
0.14
Current Ratio
1.38
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 11.65x |
| 2026-03-31 | 12.43x |
| 2025-12-31 | 6.29x |
| 2025-09-30 | 2.63x |
| 2025-06-30 | -1.02x |
| 2025-03-31 | 0.52x |
| 2024-12-31 | 0.11x |
| 2024-09-30 | 0.01x |
| 2024-06-30 | -2.74x |
| 2024-03-31 | -2.84x |
| 2023-12-31 | -5.83x |
| 2023-09-30 | -13.58x |
| 2023-06-30 | -9.46x |
| 2023-03-31 | -6.70x |
| 2022-12-31 | -8.91x |
| 2022-09-30 | -9.27x |
| 2022-06-30 | -8.48x |
| 2022-03-31 | -18.85x |
| 2021-12-31 | -31.58x |
| 2021-09-30 | -35.59x |
| 2021-06-30 | -2.03x |
| 2021-03-31 | -0.10x |
| 2020-12-31 | 0.55x |
| 2020-09-30 | 0.42x |
| 2020-06-30 | 0.02x |
| 2020-03-31 | 3.35x |
